TY  - CONF
N1  - This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions.
M2  - Virtual
EP  - 4
AV  - public
VL  - 70
Y1  - 2021/06//
TI  - 131-LB: The Impact of Canagliflozin on the Risk of Neuropathy Events: Results from the CREDENCE Trial
A1  - Liao, Jinlan
A1  - Kang, Amy
A1  - Xia, Chao
A1  - Arnott, Clare
A1  - Di Tanna, Gian Luca
A1  - Krishnan, Arun V
A1  - Pollock, Carol A
A1  - Agarwal, Rajiv
A1  - Bakris, George
A1  - Heerspink, Hiddo L
A1  - Levin, Adeera
A1  - De Zeeuw, Dick
A1  - Neal, Bruce
A1  - Zhang, Hong
A1  - Wheeler, David C
A1  - Zinman, Bernard
A1  - Mahaffey, Kenneth W
A1  - Perkovic, Vlado
A1  - Jardine, Meg J
A1  - Smyth, Brendan
T2  - 81st Scientific Sessions
SN  - 0012-1797
UR  - https://doi.org/10.2337/db21-131-LB
PB  - AMER DIABETES ASSOC
ID  - discovery10142599
ER  -